Literature DB >> 28678000

Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.

Samantha M McEvedy1, Jan Cameron2, Eugene Lugg3, Jennifer Miller4, Chris Haedtke4, Muna Hammash5, Martha J Biddle4, Kyoung Suk Lee6, Justin A Mariani2,3,7, Chantal F Ski8, David R Thompson8, Misook Lee Chung4, Debra K Moser4.   

Abstract

BACKGROUND: End-of-life implantable cardioverter defibrillator deactivation discussions should commence before device implantation and be ongoing, yet many implantable cardioverter defibrillators remain active in patients' last days. AIM: To examine associations among implantable cardioverter defibrillator knowledge, patient characteristics and attitudes to implantable cardioverter defibrillator deactivation.
DESIGN: Cross-sectional survey using the Experiences, Attitudes and Knowledge of End-of-Life Issues in Implantable Cardioverter Defibrillator Patients Questionnaire. Participants were classified as insufficient or sufficient implantable cardioverter defibrillator knowledge and the two groups were compared. SETTING/PARTICIPANTS: Implantable cardioverter defibrillator recipients ( n = 270, mean age 61 ± 14 years; 73% male) were recruited from cardiology and implantable cardioverter defibrillator clinics attached to two tertiary hospitals in Melbourne, Australia, and two in Kentucky, the United States.
RESULTS: Participants with insufficient implantable cardioverter defibrillator knowledge ( n = 77, 29%) were significantly older (mean age 66 vs 60 years, p = 0.001), less likely to be Caucasian (77% vs 87%, p  = 0.047), less likely to have received implantable cardioverter defibrillator shocks (26% vs 40%, p = 0.031), and more likely to have indications of mild cognitive impairment (Montreal Cognitive Assessment score <24: 44% vs 16%, p < 0.001). Insufficient implantable cardioverter defibrillator knowledge was associated with attitudes suggesting unwillingness to discuss implantable cardioverter defibrillator deactivation, even during the last days towards end of life ( p < 0.05).
CONCLUSION: Implantable cardioverter defibrillator recipients, especially those who are older or have mild cognitive impairment, often have limited knowledge about implantable cardioverter defibrillator deactivation. This study identified several potential teachable moments throughout the patients' treatment trajectory. An interdisciplinary approach is required to ensure that discussions about implantable cardioverter defibrillator deactivation issues are initiated at appropriate time points, with family members ideally also included.

Entities:  

Keywords:  Implantable cardioverter defibrillator; attitudes; device deactivation; end-of-life discussions; knowledge

Mesh:

Year:  2017        PMID: 28678000      PMCID: PMC5899887          DOI: 10.1177/0269216317718438

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  32 in total

1.  Shock and patient-centered outcomes research: is an ICD shock still a critical event?

Authors:  Samuel F Sears; Kari Kirian
Journal:  Pacing Clin Electrophysiol       Date:  2010-12       Impact factor: 1.976

Review 2.  Lost in translation: examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions.

Authors:  Michael Mitar; Ana C Alba; Jane MacIver; Heather Ross
Journal:  Circ Heart Fail       Date:  2012-09-01       Impact factor: 8.790

3.  Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.

Authors:  James N Kirkpatrick; Maia Gottlieb; Priya Sehgal; Rutuke Patel; Ralph J Verdino
Journal:  Am J Cardiol       Date:  2011-09-22       Impact factor: 2.778

4.  Palliative care for people with heart failure: summary of current evidence and future direction.

Authors:  Amy Gadoud; Shona M M Jenkins; Karen J Hogg
Journal:  Palliat Med       Date:  2013-07-09       Impact factor: 4.762

Review 5.  Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.

Authors:  Loreena Hill; Sonja McIlfatrick; Brian Taylor; Lana Dixon; Mark Harbinson; Donna Fitzsimons
Journal:  Palliat Med       Date:  2014-09-19       Impact factor: 4.762

Review 6.  Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.

Authors:  Krystina B Lewis; Dawn Stacey; Dan D Matlock
Journal:  Patient       Date:  2014       Impact factor: 3.883

7.  Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life.

Authors:  Annika Kinch Westerdahl; Johanna Sjöblom; Anne-Cathrine Mattiasson; Mårten Rosenqvist; Viveka Frykman
Journal:  Circulation       Date:  2013-11-15       Impact factor: 29.690

8.  Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know?

Authors:  Claire E Raphael; Michael Koa-Wing; Nolan Stain; Ian Wright; Darrel P Francis; Prapa Kanagaratnam
Journal:  Pacing Clin Electrophysiol       Date:  2011-09-28       Impact factor: 1.976

9.  Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator.

Authors:  Ingela Thylén; Marika Wenemark; Christina Fluur; Anna Strömberg; Kärstin Bolse; Kristofer Årestedt
Journal:  Eur J Cardiovasc Nurs       Date:  2013-12-01       Impact factor: 3.908

10.  Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks?

Authors:  Ingela Thylén; Debra K Moser; Misook L Chung; Jennifer Miller; Christina Fluur; Anna Strömberg
Journal:  Int J Cardiol Heart Vessel       Date:  2013-11-13
View more
  2 in total

1.  Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.

Authors:  Rik Stoevelaar; Arianne Brinkman-Stoppelenburg; Anne Geert van Driel; Rozemarijn L van Bruchem-Visser; Dominic Amj Theuns; Rohit E Bhagwandien; Agnes Van der Heide; Judith Ac Rietjens
Journal:  Heart       Date:  2019-09-19       Impact factor: 5.994

2.  'You can't start a car when there's no petrol left': a qualitative study of patient, family and clinician perspectives on implantable cardioverter defibrillator deactivation.

Authors:  Holly Standing; Richard G Thomson; Darren Flynn; Julian Hughes; Kerry Joyce; Trudie Lobban; Stephen Lord; Dan D Matlock; Janet M McComb; Paul Paes; Chris Wilkinson; Catherine Exley
Journal:  BMJ Open       Date:  2021-07-06       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.